Cornercap Investment Counsel’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-27,470
| Closed | -$805K | – | 461 |
|
|
2017
Q3 | $805K | Buy |
27,470
+5,620
| +26% | +$157K | 0.11% | 229 |
|
|
2017
Q2 | $574K | Sell |
21,850
-34,060
| -61% | -$837K | 0.1% | 267 |
|
|
2017
Q1 | $1.31M | Buy |
55,910
+1,240
| +2% | +$30.6K | 0.22% | 130 |
|
|
2016
Q4 | $1.38M | Buy |
54,670
+13,145
| +32% | +$332K | 0.24% | 125 |
|
|
2016
Q3 | $1.17M | Buy |
+41,525
| New | +$1.06M | 0.21% | 130 |
|
|
2016
Q1 | – | Sell |
-15,885
| Closed | -$556K | – | 420 |
|
|
2015
Q4 | $556K | Buy |
+15,885
| New | +$498K | 0.11% | 124 |
|
|
2014
Q4 | – | Sell |
-16,193
| Closed | -$396K | – | 361 |
|
|
2014
Q3 | $396K | Sell |
16,193
-300
| -2% | -$7.96K | 0.07% | 186 |
|
|
2014
Q2 | $472K | Sell |
16,493
-560
| -3% | -$15.6K | 0.09% | 133 |
|
|
2014
Q1 | $477K | Sell |
17,053
-11,355
| -40% | -$279K | 0.09% | 120 |
|
|
2013
Q4 | $611K | Buy |
28,408
+695
| +3% | +$12.6K | 0.11% | 95 |
|
|
2013
Q3 | $368K | Buy |
27,713
+7,995
| +41% | +$108K | 0.07% | 160 |
|
|
2013
Q2 | $273K | Buy |
+19,718
| New | +$279K | 0.06% | 210 |
|
Cornercap Investment Counsel's PMC Position: Q4 2017 in Review
Cornercap Investment Counsel sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 27,470 shares — an estimated $805K sold.
Cornercap Investment Counsel first reported a position in PMC in Q2 2013 and held it in 12 quarters. The position peaked at $1.38M in Q4 2016. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Cornercap Investment Counsel reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Cornercap Investment Counsel sold 27,470 PharMerica Corporation shares in Q4 2017, an estimated $805K.
- Cornercap Investment Counsel first reported a position in PharMerica Corporation in Q2 2013 and held it in 12 quarters.
- Cornercap Investment Counsel's PharMerica Corporation position peaked at $1.38M in Q4 2016.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Cornercap Investment Counsel's 13F filing for Q4 2017, filed 14 Feb 2018.